PT1128827E - Comprimido multicamada compreendendo rosiglitazona - Google Patents

Comprimido multicamada compreendendo rosiglitazona Download PDF

Info

Publication number
PT1128827E
PT1128827E PT99956029T PT99956029T PT1128827E PT 1128827 E PT1128827 E PT 1128827E PT 99956029 T PT99956029 T PT 99956029T PT 99956029 T PT99956029 T PT 99956029T PT 1128827 E PT1128827 E PT 1128827E
Authority
PT
Portugal
Prior art keywords
rosiglitazone
multilayer tablet
multilayer
tablet
Prior art date
Application number
PT99956029T
Other languages
English (en)
Inventor
Susan Marie Milosovich
Robert Glinecke
William Muldoon
Vincenzo Re
Joseph Sauer
Janet Louise Skinner
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824870.1A external-priority patent/GB9824870D0/en
Priority claimed from GBGB9912189.9A external-priority patent/GB9912189D0/en
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Publication of PT1128827E publication Critical patent/PT1128827E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
PT99956029T 1998-11-12 1999-11-12 Comprimido multicamada compreendendo rosiglitazona PT1128827E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9824870.1A GB9824870D0 (en) 1998-11-12 1998-11-12 Novel composition and use
GBGB9912189.9A GB9912189D0 (en) 1999-05-25 1999-05-25 Novel composition and use

Publications (1)

Publication Number Publication Date
PT1128827E true PT1128827E (pt) 2008-03-10

Family

ID=26314667

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99956029T PT1128827E (pt) 1998-11-12 1999-11-12 Comprimido multicamada compreendendo rosiglitazona

Country Status (39)

Country Link
EP (3) EP1917962A1 (pt)
JP (1) JP2002529505A (pt)
KR (2) KR100732599B1 (pt)
CN (1) CN1289081C (pt)
AP (2) AP2008004490A0 (pt)
AR (2) AR023700A1 (pt)
AT (1) ATE382352T1 (pt)
AU (1) AU768578B2 (pt)
BG (2) BG65444B1 (pt)
BR (1) BR9915215A (pt)
CA (1) CA2350659C (pt)
CO (1) CO5190673A1 (pt)
CY (1) CY1107909T1 (pt)
CZ (1) CZ20011628A3 (pt)
DE (1) DE69937898T2 (pt)
DK (1) DK1128827T3 (pt)
DZ (1) DZ2937A1 (pt)
EA (3) EA200702648A1 (pt)
EG (2) EG24463A (pt)
ES (1) ES2299269T3 (pt)
HK (1) HK1040909B (pt)
HR (2) HRP20010342B1 (pt)
HU (1) HUP0104307A3 (pt)
ID (1) ID29344A (pt)
IL (2) IL143003A0 (pt)
MY (1) MY135973A (pt)
NO (1) NO20012351L (pt)
NZ (2) NZ526440A (pt)
OA (1) OA11676A (pt)
PE (1) PE20001428A1 (pt)
PL (1) PL198717B1 (pt)
PT (1) PT1128827E (pt)
RS (1) RS50208B (pt)
SI (1) SI1128827T1 (pt)
SK (1) SK286937B6 (pt)
TR (2) TR200101337T2 (pt)
TW (2) TWI246920B (pt)
UY (2) UY25798A1 (pt)
WO (1) WO2000028990A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
MY125516A (en) 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
AU783099B2 (en) * 2000-01-07 2005-09-22 Rohm Gmbh & Co. Kg Selective activation of a TH1 or TH2 lymphocyte regulated immune response
ATE380022T1 (de) * 2001-01-31 2007-12-15 Evonik Roehm Gmbh Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen
ES2259736T3 (es) * 2001-12-21 2006-10-16 Smithkline Beecham Corporation Regimen de dosificacion para activadores de ppar-gamma-.
PE20030800A1 (es) * 2002-02-12 2003-10-31 Glaxo Group Ltd Forma de dosificacion oral de liberacion controlada
AU2003281181A1 (en) * 2002-07-11 2004-02-02 Takeda Pharmaceutical Company Limited Process for producing coated preparation
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
CA2514879C (en) 2003-01-03 2014-09-16 Shire Laboratories Inc. Two or more enteric materials to regulate drug release
KR101114808B1 (ko) 2003-01-29 2012-02-15 다케다 야쿠힌 고교 가부시키가이샤 피복 제제의 제조법
ES2241478B1 (es) * 2004-02-13 2006-11-16 Lacer S.A. Preparacion farmaceutica para la liberacion sostenida de un principio farmaceuticamente activo.
FI20060501L (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi vatsassa
EP2731593A4 (en) * 2011-07-14 2015-07-01 Able Cerebral Llc COMPOSITION, DEVICE AND METHOD FOR DELAYED AND PROLONGED DELIVERY OF ENERGY MOLECULES TO THE BRAIN
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
DK173350B1 (da) 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
JPH06779B2 (ja) 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US4791125A (en) 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
MX15171A (es) 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
WO1989008650A1 (en) 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1991007107A1 (en) 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
KR930701436A (ko) 1990-07-03 1993-06-11 오노다 마사아이 비스헤테로환 화합물
HUT70153A (en) 1990-08-23 1995-09-28 Pfizer Hypoglycemic hydroxyurea derivatives
JPH04210683A (ja) 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
HUT68370A (en) 1991-04-11 1995-06-28 Takeda Chemical Industries Ltd Thiazolidine derivatives, pharmaceutical compositions containing them and process for their production
US5183823A (en) 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
TW222626B (pt) 1991-07-22 1994-04-21 Pfizer
FR2680512B1 (fr) 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH05271204A (ja) 1992-03-26 1993-10-19 Japan Tobacco Inc 新規なトリアジン誘導体
US5264451A (en) 1992-04-07 1993-11-23 American Home Products Corporation Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones
JPH07505647A (ja) 1992-04-10 1995-06-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 複素環化合物および２型糖尿病の治療におけるそれらの使用
WO1993022445A1 (en) 1992-05-05 1993-11-11 The Upjohn Company A process for producing pioglitazone metabolite
NZ253742A (en) 1992-07-03 1997-06-24 Smithkline Beecham Plc Heterocyclylaminoalkoxy substituted phenyl derivatives and pharmaceutical compositions
US5326770A (en) * 1992-07-17 1994-07-05 The Du Pont Merck Pharmaceutical Company Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals
US5232945A (en) 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US5952509A (en) * 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
JP3256841B2 (ja) * 1996-06-27 2002-02-18 武田薬品工業株式会社 ベンズアルデヒド化合物の製造法
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process
AU6576398A (en) * 1997-03-24 1998-10-20 Galderma Research & Development, S.N.C. Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
IL183972A0 (en) 2007-10-31
HRP20010342B1 (en) 2008-04-30
CO5190673A1 (es) 2002-08-29
TR200503846T2 (tr) 2007-01-22
EA200100540A1 (ru) 2001-10-22
SI1128827T1 (sl) 2008-06-30
CA2350659C (en) 2009-06-09
BG65444B1 (bg) 2008-08-29
EP1128827B1 (en) 2008-01-02
RS50208B (sr) 2009-07-15
HK1040909B (zh) 2008-08-01
KR20010073229A (ko) 2001-07-31
AP1901A (en) 2008-10-24
CA2350659A1 (en) 2000-05-25
UY25800A1 (es) 2000-08-21
EA200702648A1 (ru) 2008-10-30
KR100732599B1 (ko) 2007-06-27
TWI246920B (en) 2006-01-11
AP2008004490A0 (en) 2008-06-30
CY1107909T1 (el) 2013-09-04
AR023699A1 (es) 2002-09-04
JP2002529505A (ja) 2002-09-10
HUP0104307A2 (hu) 2002-07-29
EP1128827A1 (en) 2001-09-05
EA007608B1 (ru) 2006-12-29
NO20012351L (no) 2001-07-04
DE69937898T2 (de) 2009-01-02
CN1333683A (zh) 2002-01-30
BR9915215A (pt) 2001-07-31
BG105570A (en) 2002-02-28
ID29344A (id) 2001-08-23
EG24463A (en) 2009-07-16
BG109893A (bg) 2008-11-28
NZ511611A (en) 2003-10-31
MY135973A (en) 2008-07-31
KR20060097140A (ko) 2006-09-13
PE20001428A1 (es) 2001-02-08
PL198717B1 (pl) 2008-07-31
DK1128827T3 (da) 2008-04-28
DZ2937A1 (fr) 2004-03-15
AU768578B2 (en) 2003-12-18
CN1289081C (zh) 2006-12-13
ES2299269T3 (es) 2008-05-16
TR200101337T2 (tr) 2001-11-21
EA200601144A1 (ru) 2007-02-27
TWI257305B (en) 2006-07-01
YU36401A (sh) 2004-05-12
HUP0104307A3 (en) 2003-12-29
EG22344A (en) 2002-12-31
SK6432001A3 (en) 2001-12-03
EP1815855A1 (en) 2007-08-08
IL143003A0 (en) 2002-04-21
CZ20011628A3 (cs) 2001-12-12
UY25798A1 (es) 2000-12-29
OA11676A (en) 2005-01-12
WO2000028990A1 (en) 2000-05-25
DE69937898D1 (de) 2008-02-14
HK1040909A1 (en) 2002-06-28
NZ526440A (en) 2005-01-28
HRP20080117A2 (en) 2008-10-31
NO20012351D0 (no) 2001-05-11
AR023700A1 (es) 2002-09-04
ATE382352T1 (de) 2008-01-15
SK286937B6 (sk) 2009-07-06
TW200505436A (en) 2005-02-16
PL348153A1 (en) 2002-05-06
EP1917962A1 (en) 2008-05-07
AU1272900A (en) 2000-06-05
HRP20010342A2 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
GB2356794B (en) Multi-layer outsole
IL141439A0 (en) Immediate release tablet
GB9815880D0 (en) Heterocycles
GB9804426D0 (en) Heterocycles
HK1040909A1 (en) Multilayer tablet comprising rosiglitazone
DE69919741D1 (en) Amphiphile blockcopolymere
GB9810354D0 (en) Heterocycles
AU141186S (en) Tablet
HUP0104047A3 (en) Tablet dispenser
HK1042879A1 (zh) 貯片盒
GB9826000D0 (en) Tablets
HUP0103163A3 (en) Exactly divisible tablet
GB9821898D0 (en) Heterocycles
AU5556699A (en) Multilayer detergent tablet with different hardness
GB9914763D0 (en) Antimalarial compounds
EG22251A (en) Alarmanlage mit computer
GB9818499D0 (en) Multi-layer pipeliner
GB9815148D0 (en) Tablet dispensers
CA80449S (en) Tablet
CA80450S (en) Tablet
CA80217S (en) Tablet
AU135526S (en) A tablet
AU135525S (en) A tablet
AU135527S (en) A tablet
AU139135S (en) A tablet